Epoxomicin 2mg 2mg | Purity Not Available
Adooq Bioscience
Epoxomicin is a potent anti-tumor agent isolated from Actinomycetes that is used as a selective and irreversible inhibitor of the 20S proteasome.
More Information Supplier PageEpoxomicin is a potent anti-tumor agent isolated from Actinomycetes that is used as a selective and irreversible inhibitor of the 20S proteasome.
More Information Supplier PageEpoxomicin is a potent anti-tumor agent isolated from Actinomycetes that is used as a selective and irreversible inhibitor of the 20S proteasome.
More Information Supplier Page(+)-JQ1 is a potent, high affinity, selective BET bromodomain inhibitor.
More Information Supplier Page(+)-JQ1 is a potent, high affinity, selective BET bromodomain inhibitor.
More Information Supplier Page(+)-JQ1 is a potent, high affinity, selective BET bromodomain inhibitor.
More Information Supplier Page(+)-JQ1 is a potent, high affinity, selective BET bromodomain inhibitor.
More Information Supplier Page(+)-JQ1 is a potent, high affinity, selective BET bromodomain inhibitor.
More Information Supplier PagePRT2607, also known as PRT062607, P505-15, and BIIB057, is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier PagePRT2607, also known as PRT062607, P505-15, and BIIB057, is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
More Information Supplier Page